21 May 2021 : Clinical Research
Aspiration Thrombectomy in Patients with Large Vessel Occlusion and Mild Stroke: A Single-Center Experience
Jozef Haring12ABEF, Miroslav Mako13BC, Ján Haršány24BC, Georgi Krastev1ADF, Matúš Hoferica4BCD, Andrej Klepanec4ADEF*DOI: 10.12659/MSM.930014
Med Sci Monit 2021; 27:e930014
Table 1 Baseline clinical characteristics of patients.
| All patients, n=27 | Anterior circulation, n=19 | Posterior circulation, n=8 | P value | |
|---|---|---|---|---|
| Age, y, mean±SD | 69.8±12.3 | 70.8±13.1 | 67.4±10.4 | 0.52 |
| Male, n (%) | 11 (40.7) | 7 (36.8) | 4 (50) | 0.53 |
| Hypertension, n (%) | 21 (77.8) | 16 (84.2) | 5 (62.5) | 0.22 |
| CAD, n (%) | 5 (18.5) | 4 (21.1) | 1 (12.5) | 0.61 |
| Atrial fibrillation, n (%) | 12 (44.4) | 8 (42.1) | 4 (50) | 0.71 |
| Diabetes mellitus, n (%) | 7 (25.9) | 5 (26.3) | 2 (25) | 0.94 |
| Dyslipidemia, n (%) | 21 (77.8) | 15 (78.9) | 6 (75) | 0.83 |
| History of stroke, n (%) | 2 (7.4) | 0 (0) | 2 (25) | 0.03 |
| Malignity, n (%) | 1 (3.7) | 1 (5.3) | 0 (0) | 0.51 |
| Smoking, n (%) | 4 (14.8) | 3 (15.8) | 1 (12.5) | 0.83 |
| Alcohol abuse, n (%) | 2 (7.4) | 1 (5.3) | 1 (12.5) | 0.52 |
| Antithrombotics, n (%) | 7 (25.9) | 4 (21.1) | 4 (50) | 0.14 |
| Anticoagulants, n (%) | 1 (3.7) | 1 (5.3) | 0 (0) | 0.51 |
| Pre-stroke mRs 0–1, n (%) | 25 (92.6) | 17 (89.5) | 8 (100) | 0.35 |
| Pre-stroke mRs >2, n (%) | 2 (7.4) | 2 (10.5) | 0 (0) | 0.35 |
| Baseline NIHSS score, median (min–max) | 4 (2–5) | 4 (2–5) | 3.5 (2–5) | |
| Baseline blood sugar, median (min–max) | 6.5 (5.6–22.5) | 6.5 (5.6–22.5) | 6.7 (5.64–14.0) | |
| Baseline systolic blood pressure, mean±SD | 150.8±13.5 | 150.3±14 | 152±13 | 0.77 |
| Baseline diastolic blood pressure, mean±SD | 81.6±9.8 | 80.7±10.4 | 83.6±8.6 | 0.49 |
| Large atherothrombotic, n (%) | 12 (44.4) | 9 (47.4) | 3 (37.5) | 0.64 |
| Cardioembolic, n (%) | 12 (44.4) | 8 (42.1) | 4 (50) | 0.71 |
| Lacunar, n (%) | 0 (0) | 0 (0) | 0 (0) | NA |
| Other, n (%) | 0 (0) | 0 (0) | 0 (0) | NA |
| Unknown, n (%) | 3 (11.1) | 2 (10.5) | 1 (12.5) | 0.88 |
| CAD – coronary artery disease; TOAST – Trial of Org 10172 in Acute Stroke Treatment; SD – standard deviation; NIHSS – National Institutes of Health Stroke Scale; mRs – modified Ranking scale. | ||||






